Review: Magnetic resonance spectroscopy studies of pediatric major depressive disorder

Depression Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Kondo, Douglas G ^a,b   Hellem, Tracy L ^a   Sung, Young Hoon ^a   Kim, Namkug ^a   Jeong, Eun Kee ^b   Delmastro, Kristen K ^a   Shi, Xianfeng ^a   Renshaw, Perry F ^a  

^a The Brain Institute at the University of Utah   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054090643     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2011/650450     Document Type: Review

References (143)

1. Goodman W. K., Research on Biomarkers for Mental Disorders. National Institute of Mental Health, Bethesda, Md, USA, 2009 http://www.nimh.nih.gov/ research-funding/grants/concept-clearances/2009/research-on-biomarkers-for- mental-disorders.shtml?WT.mc-id=rss
2. Atkinson A. J. Jr., Colburn W. A., DeGruttola V. G., DeMets D. L., Downing G. J., Hoth D. F., Oates J. A., Peck C. C., Schooley R. T., Spilker B. A., Woodcock J., Zeger S. L., Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics 2001 69 3 89 95 2-s2.0-0035100888 10.1067/mcp.2001.113989 (Pubitemid 32225406)
3. Regier D. A., Narrow W. E., Kuhl E. A., Kupfer D. J., The conceptual development of DSM-V. American Journal of Psychiatry 2009 166 6 645 650 2-s2.0-66949114541 10.1176/appi.ajp.2009.09020279
4. Charney D. S., Barlow D. H., Botterton K., Cohen J. D., Goldman D., Gur R. E., Kupfer D. J., First M. B., Regier D. A., Neuroscience research agenda to guide development of a pathophysiologically based classification system. A Research Agenda for DSM-V 2002 Arlington, Va, USA American Psychiatric Publishing
5. Phillips M. L., The emerging role of neuroimaging in psychiatry: characterizing treatment-relevant endophenotypes. American Journal of Psychiatry 2007 164 5 697 699 2-s2.0-34249334312 10.1176/appi.ajp.164.5.697 (Pubitemid 46808517)
6. Singh I., Rose N., Biomarkers in psychiatry. Nature 2009 460 7252 202 207 2-s2.0-67650459886 10.1038/460202a
7. Hyman S. E., Can neuroscience be integrated into the DSM-V? Nature Reviews Neuroscience 2007 8 9 725 732 2-s2.0-34548011214 10.1038/nrn2218 (Pubitemid 47283150)
8. Reynolds C. F. III, Lewis D. A., Detre T., Schatzberg A. F., Kupfer D. J., The future of psychiatry as clinical neuroscience. Academic Medicine 2009 84 4 446 450 2-s2.0-65249086721 10.1097/ACM.0b013e31819a8052
9. Pavuluri M. N., Sweeney J. A., Integrating functional brain neuroimaging and developmental cognitive neuroscience in child psychiatry research. Journal of the American Academy of Child and Adolescent Psychiatry 2008 47 11 1273 1288 2-s2.0-55849146998 10.1097/CHI.0b013e318185d2d1
10. Serene J. A., Ashtari M., Szeszko P. R., Kumra S., Neuroimaging studies of children with serious emotional disturbances: a selective review. Canadian Journal of Psychiatry 2007 52 3 135 145 2-s2.0-34248524770 (Pubitemid 46761956)
11. Gerber A. J., Peterson B. S., Applied brain imaging. Journal of the American Academy of Child and Adolescent Psychiatry 2008 47 3 239 2-s2.0-45549108607 10.1097/CHI.0b013e3181635e00
12. Drevets W. C., Price J. L., Furey M. L., Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function 2008 213 1-2 93 118 2-s2.0-50249084453 10.1007/s00429-008-0189-x
13. Leibenluft E., Skating to where the puck will be: the importance of neuroimaging literacy in child psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry 2008 47 11 1213 1216 2-s2.0-55849128889 10.1097/CHI.0b013e318185dab8
14. Friedman J. N. W., Hurley R. A., Taber K. H., Bipolar disorder: imaging state versus trait. Journal of Neuropsychiatry and Clinical Neurosciences 2006 18 3 296 301 2-s2.0-33750125629 10.1176/appi.neuropsych.18.3.296
15. Rot M. A. H., Mathew S. J., Charney D. S., Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal 2009 180 3 305 313 2-s2.0-61449197838 10.1503/cmaj.080697
16. World Health Organization, The Global Burden of Disease: 2004 Update 2008 1st Geneva, Switzerland WHO Press
17. Kessler R. C., Avenevoli S., Green J., Gruber M. J., Guyer M., He Y., Jin R., Kaufman J., Sampson N. A., Zaslavsky A. M., Merikangas K. R., National comorbidity survey replication adolescent supplement (NCS-A): III. concordance of DSM-IV/CIDI diagnoses with clinical reassessments. Journal of the American Academy of Child and Adolescent Psychiatry 2009 48 4 386 399 2-s2.0-67649116864 10.1097/CHI.0b013e31819a1cbc
18. Paus T., Keshavan M., Giedd J. N., Why do many psychiatric disorders emerge during adolescence? Nature Reviews Neuroscience 2008 9 12 947 957 2-s2.0-56549127348 10.1038/nrn2513
19. Birmaher B., Brent D., Bernet W., Bukstein O., Walter H., Benson R. S., Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2007 46 11 1503 1526
20. Lewinsohn P. M., Hops H., Roberts R. E., Seeley J. R., Andrews J. A., Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology 1993 102 1 133 144 2-s2.0-0027419593 10.1037//0021-843X.102.1.133 (Pubitemid 23089571)
21. Fergusson D. M., Horwood L. J., Ridder E. M., Beautrais A. L., Subthreshold depression in adolescence and mental health outcomes in adulthood. Archives of General Psychiatry 2005 62 1 66 72 2-s2.0-11844258175 10.1001/archpsyc.62.1.66 (Pubitemid 40096072)
22. Lynch F. L., Clarke G. N., Estimating the economic burden of depression in children and adolescents. American Journal of Preventive Medicine 2006 31 6, supplement 1 143 151 2-s2.0-33845394509 10.1016/j.amepre.2006.07.001 (Pubitemid 44920290)
23. Kessler R. C., Avenevoli S., Ries Merikangas K., Mood disorders in children and adolescents: an NIMH perspective. Biological Psychiatry 2001 49 12 962 969 2-s2.0-0035875359 10.1016/S0006-3223(01)01128-3 (Pubitemid 32595455)
24. Fombonne E., Wostear G., Cooper V., Harrington R., Rutter M., The Maudsley long-term follow-up of child and adolescent depression: 2. Suicidality, criminality and social dysfunction in adulthood. British Journal of Psychiatry 2001 179 218 223 2-s2.0-0034849693 10.1192/bjp.179.3.218 (Pubitemid 32844282)
25. Fombonne E., Wostear G., Cooper V., Harrington R., Rutter M., The Maudsley long-term follow-up of child and adolescent depression: I. Psychiatric outcomes in adulthood. British Journal of Psychiatry 2001 179 210 217 2-s2.0-0034853571 10.1192/bjp.179.3.210 (Pubitemid 32844281)
26. Vitiello B., Rohde P., Silva S., Wells K., Casat C., Waslick B., Simons A., Reinecke M., Weller E., Kratochvil C., Walkup J., Pathak S., Robins M., March J., Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry 2006 45 12 1419 1426 2-s2.0-33845410571 10.1097/01.chi.0000242229. 52646.6e (Pubitemid 44900915)
27. Weissman M. M., Wolk S., Goldstein R. B., Moreau D., Adams P., Greenwald S., Klier C. M., Ryan N. D., Dahl R. E., Wickramaratne P., Depressed adolescents grown up. Journal of the American Medical Association 1999 281 18 1707 1713 2-s2.0-0033549096 10.1001/jama.281.18.1707 (Pubitemid 29226480)
28. Purcell E. M., Torrey H. C., Pound R. V., Resonance absorption by nuclear magnetic moments in a solid. Physical Review 1946 69 1-2 37 38 2-s2.0-36149002175 10.1103/PhysRev.69.37
29. Bloch F., Hansen W. W., Packard M., Nuclear induction. Physical Review 1946 69 3-4 127 2-s2.0-33748203505 10.1103/PhysRev.69.127
30. Soares D. P., Law M., Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clinical Radiology 2009 64 1 12 21 2-s2.0-57349134532 10.1016/j.crad.2008.07.002
31. Danielsen E. R., Ross B., Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases 1999 1st New York, NY, USA Marcel Dekker
32. Kato T., Inubushi T., Kato N., Magnetic resonance spectroscopy in affective disorders. Journal of Neuropsychiatry and Clinical Neurosciences 1998 10 2 133 147 2-s2.0-0031745708 (Pubitemid 28241361)
33. Prost R. W., Magnetic resonance spectroscopy. Medical Physics 2008 35 10 4530 4544
34. Agarwal N., Port J. D., Bazzocchi M., Renshaw P. F., Update on the use of MR for assessment and diagnosis of psychiatric diseases. Radiology 2010 255 1 23 41 2-s2.0-0344838483 10.1148/radiol.09090339
35. de Graaf R. A., In Vivo NMR Spectroscopy: Principles and Techniques 2010 2nd West Sussex, UK John Wiley & Sons
36. Dager S. R., Corrigan N. M., Richards T. L., Posse S., Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Topics in Magnetic Resonance Imaging 2008 19 2 81 96 2-s2.0-67649817078 10.1097/RMR.0b013e318181e0be
37. Kreis R., Ernst T., Ross B. D., Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magnetic Resonance in Medicine 1993 30 4 424 437 2-s2.0-0027451907 10.1002/mrm.1910300405 (Pubitemid 23300070)
38. Novotny E. J. Jr., Fulbright R. K., Pearl P. L., Gibson K. M., Rothman D. L., Magnetic resonance spectroscopy of neurotransmitters in human brain. Annals of Neurology 2003 54 6, supplement S25 S31 2-s2.0-0042868561 10.1002/ana.10697 (Pubitemid 36903851)
39. Bergles D. E., Diamond J. S., Jahr C. E., Clearance of glutamate inside the synapse and beyond. Current Opinion in Neurobiology 1999 9 3 293 298 2-s2.0-0033152742 10.1016/S0959-4388(99)80043-9 (Pubitemid 29267599)
40. Moore C. M., Biederman J., Wozniak J., Mick E., Aleardi M., Wardrop M., Dougherty M., Harpold T., Hammerness P., Randall E., Lyoo I. K., Renshaw P. F., Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. Journal of Affective Disorders 2007 99 1-3 19 25 2-s2.0-33847052084 10.1016/j.jad.2006.08.023 (Pubitemid 46275021)
41. Rothman D. L., Petroff O. A. C., Behar K. L., Mattson R. H., Localized 1H NMR measurements of γ -aminobutyric acid in human brain in vivo. Proceedings of the National Academy of Sciences of the United States of America 1993 90 12 5662 5666 2-s2.0-0027335880 (Pubitemid 23176221)
42. Tallan H. H., Moore S., Stein W. H., N-Acetyl-L-aspartic acid in brain. The Journal of Biological Chemistry 1956 219 1 257 264
43. Benarroch E. E., N-Acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008 70 16 1353 1357 2-s2.0-42249100179 10.1212/01.wnl.0000311267.63292.6c (Pubitemid 351550340)
44. Moffett J. R., Ross B., Arun P., Madhavarao C. N., Namboodiri A. M. A., N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Progress in Neurobiology 2007 81 2 89 131 2-s2.0-33847141978 10.1016/j.pneurobio.2006.12. 003 (Pubitemid 46282272)
45. Moore G. J., Galloway M. P., Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacology Bulletin 2002 36 2 5 23 2-s2.0-0036514755
46. Yildiz-Yesiloglu A., Ankerst D. P., Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006 30 6 969 995 2-s2.0-33846402816 10.1016/j.pnpbp.2006.03.012 (Pubitemid 43928209)
47. Friedman S. D., Brooks W. M., Jung R. E., Chiulli S. J., Sloan J. H., Montoya B. T., Hart B. L., Yeo R. A., Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology 1999 52 7 1384 1391 2-s2.0-0033594532 (Pubitemid 29190528)
48. Kwock L., Smith J. K., Castillo M., Ewend M. G., Collichio F., Morris D. E., Bouldin T. W., Cush S., Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. Lancet Oncology 2006 7 10 859 868 2-s2.0-33749063621 10.1016/S1470-2045(06)70905-6 (Pubitemid 44464079)
49. Smith J. K., Castillo M., Kwock L., MR spectroscopy of brain tumors. Magnetic Resonance Imaging Clinics of North America 2003 11 3 415 429 2-s2.0-0344876657 10.1016/S1064-9689(03)00061-8 (Pubitemid 37484244)
50. Rosen Y., Lenkinski R. E., Recent advances in magnetic resonance neurospectroscopy. Neurotherapeutics 2007 4 3 330 345 2-s2.0-34250718053 10.1016/j.nurt.2007.04.009 (Pubitemid 46962408)
51. Lopez-Villegas D., Lenkinski R. E., Wehrli S. L., Ho W.-Z., Douglas S. D., Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magnetic Resonance in Medicine 1995 34 1 32 38 2-s2.0-0029014640 10.1002/mrm.1910340107
52. Gujar S. K., Maheshwari S., Björkman-Burtscher I., Sundgren P. C., Magnetic resonance spectroscopy. Journal of Neuro-Ophthalmology 2005 25 3 217 226 2-s2.0-24944562078 10.1097/01.wno.0000177307.21081.81 (Pubitemid 41306683)
53. Frangou S., Williams S. C. R., Magnetic resonance spectroscopy in psychiatry basic principles and applications. British Medical Bulletin 1996 52 3 474 485 2-s2.0-0029739349 (Pubitemid 26329148)
54. Radda G. K., Control, bioenergetics, and adaptation in health and disease: noninvasive biochemistry from nuclear magnetic resonance. FASEB Journal 1992 6 12 3032 3038 2-s2.0-0026754563
55. 31P-NMR on developing dog brain. FEBS Letters 1984 178 1 137 142 2-s2.0-0021740333 10.1016/0014-5793(84)81257-0 (Pubitemid 15216602)
56. Glonek T., Kopp S. J., Kot E., P-31 nuclear magnetic resonance analysis of brain: the perchloric acid extract spectrum. Journal of Neurochemistry 1982 39 5 1210 1219 2-s2.0-0020367858 (Pubitemid 13220373)
57. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations. Journal of Neuropathology and Experimental Neurology 1987 46 4 419 430 2-s2.0-0023161734 (Pubitemid 17105150)
58. Reddy R., Keshavan M. S., Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids 2003 69 6 401 405 2-s2.0-0344873214 10.1016/j.plefa.2003.08.011 (Pubitemid 37464049)
59. 31P-NMR study of brain phospholipid structures in vivo. Biochimica et Biophysica Acta 1991 1085 2 257 264 2-s2.0-0025737088 10.1016/0005-2760(91)90102-N
60. 31P-NMR. Biochimica et Biophysica Acta 1992 1117 3 251 257 2-s2.0-0026670355 10.1016/0304-4165(92) 90021-L
61. Petroff O. A., Prichard J. W., Behar K. L., Alger J. R., den Hollander J. A., Shulman R. G., Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology 1985 35 6 781 788 (Pubitemid 15025280)
62. Erecinska M., Silver I. A., ATP and brain function. Journal of Cerebral Blood Flow and Metabolism 1989 9 1 2 19 2-s2.0-0024535292 (Pubitemid 19053430)
63. Renshaw P. F., Parow A. M., Hirashima F., Ke Y., Moore C. M., Frederick B. D., Fava M., Hennen J., Cohen B. M., Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. American Journal of Psychiatry 2001 158 12 2048 2055 2-s2.0-0035180434 10.1176/appi.ajp.158.12.2048 (Pubitemid 33104113)
64. Webb F. G., Sailasuta N., Kohler S. J., Raidy T., Moats R. A., Hurd R. E., Automated single-voxel proton MRS: technical development and multisite verification. Magnetic Resonance in Medicine 1994 31 4 365 373 2-s2.0-0028224243 (Pubitemid 24108265)
65. Alvarez-Linera J., 3 T MRI: advances in brain imaging. European Journal of Radiology 2008 67 3 415 426 2-s2.0-49049102065 10.1016/j.ejrad.2008.02.045
66. Lyoo I. K., Renshaw P. F., Magnetic resonance spectroscopy: current and future applications in psychiatric research. Biological Psychiatry 2002 51 3 195 207 2-s2.0-0036468919 10.1016/S0006-3223(01)01313-0 (Pubitemid 34142631)
67. Iosifescu D. V., Bolo N. R., Nierenberg A. A., Jensen J. E., Fava M., Renshaw P. F., Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biological Psychiatry 2008 63 12 1127 1134 2-s2.0-44349109616 10.1016/j.biopsych.2007.11.020
68. Moore C. M., Christensen J. D., Lafer B., Fava M., Renshaw P. F., Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. American Journal of Psychiatry 1997 154 1 116 118 2-s2.0-0031016616 (Pubitemid 27020205)
69. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. European Archives of Psychiatry and Clinical Neuroscience 1998 248 6 289 295 2-s2.0-0032217116 10.1007/s004060050052 (Pubitemid 29026984)
70. 31P MRS for measuring brain ATP synthesis. Proceedings of the National Academy of Sciences of the United States of America 2009 106 10 3988 3993 2-s2.0-62649084065 10.1073/pnas.0806516106
71. Kessler R. C., Berglund P., Demler O., Jin R., Merikangas K. R., Walters E. E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005 62 6 593 602 2-s2.0-20344385026 10.1001/archpsyc.62.6.593 (Pubitemid 40973434)
72. Belmaker R. H., Bipolar disorder. New England Journal of Medicine 2004 351 5 476 518 2-s2.0-3342900250 10.1056/NEJMra035354 (Pubitemid 38988597)
73. Mann J. J., The medical management of depression. New England Journal of Medicine 2005 353 17 1819 1834 2-s2.0-3042635724 10.1056/NEJMra050730 (Pubitemid 41549894)
74. Steingard R. J., Yurgelun-Todd D. A., Hennen J., Moore J. C., Moore C. M., Vakili K., Young A. D., Katic A., Beardslee W. R., Renshaw P. F., Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biological Psychiatry 2000 48 11 1053 1061 2-s2.0-0034563665 10.1016/S0006-3223(00)00942-2
75. Kusumakar V., MacMaster F. P., Gates L., Sparkes S. J., Khan S. C., Left medial temporal cytosolic choline in early onset depression. Canadian Journal of Psychiatry 2001 46 10 959 964 2-s2.0-0035707775 (Pubitemid 34121560)
76. Farchione T. R., Moore G. J., Rosenberg D. R., Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biological Psychiatry 2002 52 2 86 92 2-s2.0-0037100287 10.1016/S0006-3223(02)01340-9 (Pubitemid 34756553)
77. Smith E. A., Russell A., Lorch E., Banerjee S. P., Rose M., Ivey J., Bhandari R., Moore G. J., Rosenberg D. R., Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biological Psychiatry 2003 54 12 1399 1405 2-s2.0-0348111554 10.1016/S0006-3223(03)00474-8 (Pubitemid 37522164)
78. Soares J. C., Krishnan K. R. R., Keshavan M. S., Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 1996 4 1 14 30 2-s2.0-0029855764 10.1002/(SICI)1522-7162(1996)4: 1<14::AID-DEPR2>3.0.CO;2-F (Pubitemid 26386329)
79. Hong S.-T., Choi C.-B., Park C., Hong K. S., Cheong C., Jeon Y.-W., Choe B.-Y., Variation of the choline signal intensity in the dorsolateral prefrontal cortex of rats exposed to the forced swimming test as detected by in vivo 1H MR spectroscopy. Journal of Neuroscience Methods 2007 165 1 89 94 2-s2.0-34447518621 10.1016/j.jneumeth.2007.05.022 (Pubitemid 47077501)
80. Mirza Y., Tang J., Russell A., Banerjee S. P., Bhandari R., Ivey J., Rose M., Moore G. J., Rosenberg D. R., Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. Journal of the American Academy of Child and Adolescent Psychiatry 2004 43 3 341 348 2-s2.0-2342440555 10.1097/00004583-200403000-00017 (Pubitemid 41615014)
81. Rosenberg D. R., Mirza Y., Russell A., Tang J., Smith J. M., Banerjee S. P., Bhandari R., Rose M., Ivey J., Boyd C., Moore G. J., Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. Journal of the American Academy of Child and Adolescent Psychiatry 2004 43 9 1146 1153 2-s2.0-4143149510 10.1097/01.chi.0000132812. 44664.2d (Pubitemid 39096872)
82. Rosenberg D. R., MacMaster F. P., Mirza Y., Smith J. M., Easter P. C., Banerjee S. P., Bhandari R., Boyd C., Lynch M., Rose M., Ivey J., Villafuerte R. A., Moore G. J., Renshaw P., Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biological Psychiatry 2005 58 9 700 704 2-s2.0-27544512117 10.1016/j.biopsych.2005.05.007 (Pubitemid 41547237)
83. Caetano S. C., Fonseca M., Olvera R. L., Nicoletti M., Hatch J. P., Stanley J. A., Hunter K., Lafer B., Pliszka S. R., Soares J. C., Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neuroscience Letters 2005 384 3 321 326 2-s2.0-20644470727 10.1016/j.neulet.2005.04.099 (Pubitemid 40836022)
84. MacMaster F. P., Kusumakar V., Choline in pediatric depression. McGill Journal of Medicine 2006 9 1 24 27 2-s2.0-33645280888
85. Mirza Y., O'Neill J., Smith E. A., Russell A., Smith J. M., Banerjee S. P., Bhandari R., Boyd C., Rose M., Ivey J., Renshaw P. F., Rosenberg D. R., Increased medial thalamic creatine- phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. Journal of Child Neurology 2006 21 2 106 111 2-s2.0-33646828485 10.1177/08830738060210020201 (Pubitemid 43772645)
86. Gabbay V., Hess D. A., Liu S., Babb J. S., Klein R. G., Gonen O., Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. American Journal of Psychiatry 2007 164 12 1881 1889 2-s2.0-38449116757 10.1176/appi.ajp.2007.06122032 (Pubitemid 351739242)
87. MacMaster F. P., Moore G. J., Russell A., Mirza Y., Taormina S. P., Buhagiar C., Rosenberg D. R., Medial temporal N-acetyl-aspartate in pediatric major depression. Psychiatry Research 2008 164 1 86 89 2-s2.0-52949146372 10.1016/j.pscychresns.2007.12.022
88. Gabbay V., Klein R. G., Alonso C. M., Babb J. S., Nishawala M., De Jesus G., Hirsch G. S., Hottinger-Blanc P. M. Z., Gonzalez C. J., Immune system dysregulation in adolescent major depressive disorder. Journal of Affective Disorders 2009 115 1-2 177 182 2-s2.0-62649122298 10.1016/j.jad.2008.07.022
89. Gabbay V., Liebes L., Katz Y., Liu S., Mendoza S., Babb J. S., Klein R. G., Gonen O., The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. Progress in Neuro- Psychopharmacology and Biological Psychiatry 2009 34 1 37 44 2-s2.0-70349614181 10.1016/j.pnpbp.2009.09.015
90. Lewinsohn P. M., Rohde P., Seeley J. R., Klein D. N., Gotlib I. H., Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults. American Journal of Psychiatry 2000 157 10 1584 1591 2-s2.0-0033815216 10.1176/appi.ajp.157.10.1584
91. Hendren R. L., De Backer I., Pandina G. J., Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry 2000 39 7 815 828 2-s2.0-0033946829 (Pubitemid 30429913)
92. Kupfer D. J., First M. B., Regier D. A., A Research Agenda for DSM-V 2002 1st Washington, DC, USA American Psychiatric Publishing
93. Phillips M. L., Frank E., Redefining bipolar disorder: toward DSM-V. American Journal of Psychiatry 2006 163 7 1135 1136 2-s2.0-33746920530 10.1176/appi.ajp.163.7.1135 (Pubitemid 44464437)
94. Stanley J. A., In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Canadian Journal of Psychiatry 2002 47 4 315 326 2-s2.0-0036299684 (Pubitemid 34728752)
95. Fuchs E., Czéh B., Kole M. H. P., Michaelis T., Lucassen P. J., Alterations of neuroplasticity in depression: the hippocampus and beyond. European Neuropsychopharmacology 2004 14 supplement 5 S481 S490 2-s2.0-8844227506 10.1016/j.euroneuro.2004.09.002 (Pubitemid 39531609)
96. Gonul A. S., Kitis O., Ozan E., Akdeniz F., Eker C., Eker O. D., Vahip S., The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006 30 1 120 125 2-s2.0-29644445741 10.1016/j.pnpbp.2005.08.017 (Pubitemid 43021331)
97. 31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression. International Journal of Geriatric Psychiatry 2009 24 8 788 797 2-s2.0-0034745001 10.1002/gps.2230
98. Mason G. F., Krystal J. H., MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. NMR in Biomedicine 2006 19 6 690 701 2-s2.0-33749495245 10.1002/nbm.1080 (Pubitemid 44515613)
99. Kraemer H. C., Wilson G. T., Fairburn C. G., Agras W. S., Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002 59 10 877 883 2-s2.0-0036792805
100. Renshaw P. F., Lafer B., Babb S. M., Fava M., Stoll A. L., Christensen J. D., Moore C. M., Yurgelun-Todd D. A., Bonello C. M., Pillay S. S., Rothschild A. J., Nierenberg A. A., Rosenbaum J. F., Cohen B. M., Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 1997 41 8 837 843 2-s2.0-0343052685 10.1016/S0006-3223(96)00256-9 (Pubitemid 27158380)
101. Stork C., Renshaw P. F., Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 2005 10 10 900 919 2-s2.0-27144492384 10.1038/sj.mp.4001711 (Pubitemid 41486483)
102. Jensen J. E., Daniels M., Haws C., Bolo N. R., Lyoo I. K., Yoon S. J., Cohen B. M., Stoll A. L., Rusche J. R., Renshaw P. F., Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. Experimental and Clinical Psychopharmacology 2008 16 3 199 206 2-s2.0-44949161985 10.1037/1064-1297.16.3.199 (Pubitemid 351822563)
103. Renshaw P. F., Lyoo I. K., Creatine Augmentation Treatment in Major Depressive Disorder Subjects. US National Library of Medicine, Bethesda, Md, USA, http://clinicaltrials.gov/ct2/show/NCT00729755
104. Carlezon W. A. Jr., Pliakas A. M., Parow A. M., Detke M. J., Cohen B. M., Renshaw P. F., Antidepressant-like effects of cytidine in the forced swim test in rats. Biological Psychiatry 2002 51 11 882 889 2-s2.0-0036603898 10.1016/S0006-3223(01)01344-0 (Pubitemid 34521936)
105. Carlezon W. A. Jr., Mague S. D., Parow A. M., Stoll A. L., Cohen B. M., Renshaw P. F., Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biological Psychiatry 2005 57 4 343 350 2-s2.0-13444254125 10.1016/j.biopsych.2004.11.038 (Pubitemid 40215763)
106. Allen P. J., D'Anci K. E., Renshaw P. F., Kararek R. B., Dietary Creatine Supplementation: A New Model of Depression? 2008 Washington, DC, USA Society for Neuroscience
107. Allen P. J., D'Anci K. E., Kanarek R. B., Renshaw P. F., Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. Neuropsychopharmacology 2009 35 534 546 2-s2.0-70349894712 10.1038/npp.2009.160
108. Kato T., Kato N., Mitochondrial dysfunction in bipolar disorder. Bipolar Disorders 2000 2 3 180 190 2-s2.0-0034280096
109. 31P-Magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression? Harvard Review of Psychiatry 2003 11 2 51 63 2-s2.0-0037355649 10.1080/10673220303959 (Pubitemid 36407107)
110. Kato T., Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 2007 21 1 1 11 2-s2.0-33846082677 (Pubitemid 46072346)
111. Shao L., Martin M. V., Watson S. J., Schatzberg A., Akil H., Myers R. M., Jones E. G., Bunney W. E., Vawter M. P., Mitochondrial involvement in psychiatric disorders. Annals of Medicine 2008 40 4 281 295 2-s2.0-42449146057 10.1080/07853890801923753 (Pubitemid 351563935)
112. Chang K., Adleman N., Wagner C., Barnea-Goraly N., Garrett A., Will neuroimaging ever be used to diagnose pediatric bipolar disorder? Development and Psychopathology 2006 18 4 1133 1146 2-s2.0-33847773085 10.1017/ S0954579406060548 (Pubitemid 46389732)
113. Goto Y., Yang C. R., Otani S., Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biological Psychiatry 2009 67 3 199 207 2-s2.0-70349894376 10.1016/j.biopsych.2009.08.026
114. Manji H. K., Quiroz J. A., Sporn J., Payne J. L., Denicoff K., Gray N. A., Zarate C. A. Jr., Charney D. S., Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biological Psychiatry 2003 53 8 707 742 2-s2.0-0038147541 10.1016/S0006-3223(03)00117-3 (Pubitemid 39658487)
115. Mathew S. J., Manji H. K., Charney D. S., Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008 33 9 2080 2092 2-s2.0-45549092746 10.1038/sj.npp.1301652 (Pubitemid 351992096)
116. Carlson P. J., Singh J. B., Zarate C. A. Jr., Drevets W. C., Manji H. K., Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 2006 3 1 22 41 2-s2.0-33244484360 10.1016/j.nurx.2005.12.009 (Pubitemid 43279517)
117. Manji H. K., Drevets W. C., Charney D. S., The cellular neurobiology of depression. Nature Medicine 2001 7 5 541 547 2-s2.0-0035034203 10.1038/87865 (Pubitemid 32448319)
118. Duman R. S., Heninger G. R., Nestler E. J., A molecular and cellular theory of depression. Archives of General Psychiatry 1997 54 7 597 606 2-s2.0-0030851206 (Pubitemid 27306570)
119. Sanacora G., Mason G. F., Rothman D. L., Behar K. L., Hyder F., Petroff O. A. C., Berman R. M., Charney D. S., Krystal J. H., Reduced cortical γ -aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Archives of General Psychiatry 1999 56 11 1043 1047 2-s2.0-0032748780 10.1001/archpsyc.56.11.1043 (Pubitemid 29526389)
120. Klempan T. A., Sequeira A., Canetti L., Lalovic A., Ernst C., Ffrench-Mullen J., Turecki G., Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Molecular Psychiatry 2009 14 2 175 189 2-s2.0-58549120972 10.1038/sj.mp.4002110
121. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C. A., Miguel-Hidalgo J. J., GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007 32 2 471 482 2-s2.0-33846251906 10.1038/sj.npp.1301234 (Pubitemid 46106953)
122. Sanacora G., Saricicek A., GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS and Neurological Disorders 2007 6 2 127 140 2-s2.0-34247628030 10.2174/187152707780363294 (Pubitemid 46681773)
123. Sanacora G., Gueorguieva R., Epperson C. N., Wu Y.-T., Appel M., Rothman D. L., Krystal J. H., Mason G. F., Subtype-specific alterations of γ -aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry 2004 61 7 705 713 2-s2.0-3042696715 10.1001/archpsyc.61.7.705 (Pubitemid 38890805)
124. Yurgelun-Todd D. A., Sava S., Dahlgren M. K., Mood Disorders. Neuroimaging Clinics of North America 2007 17 4 511 521 2-s2.0-35648962892 10.1016/j.nic.2007.08.001 (Pubitemid 350026403)
125. Gerber A. J., Peterson B. S., What is an image? Journal of the American Academy of Child and Adolescent Psychiatry 2008 47 3 245 248 2-s2.0-45549087161 10.1097/CHI.0b013e318161e509
126. Mayberg H. S., Limbic-cortical dysregulation: a proposed model of depression. Journal of Neuropsychiatry and Clinical Neurosciences 1997 9 3 471 481 2-s2.0-0030858270 (Pubitemid 27363950)
127. Davanzo P., Yue K., Thomas M. A., Belin T., Mintz J., Venkatraman T. N., Santoro E., Barnett S., McCracken J., Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. American Journal of Psychiatry 2003 160 8 1442 1452 2-s2.0-0041880362 10.1176/appi.ajp.160.8.1442 (Pubitemid 41070920)
128. Moore C. M., Biederman J., Wozniak J., Mick E., Aleardi M., Wardrop M., Dougherty M., Harpold T., Hammerness P., Randall E., Renshaw P. F., Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. American Journal of Psychiatry 2006 163 2 316 318 2-s2.0-33644991424 10.1176/appi.ajp.163.2.316 (Pubitemid 44480854)
129. Carrey N., MacMaster F. P., Fogel J., Sparkes S., Waschbusch D., Sullivan S., Schmidt M., Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clinical Neuropharmacology 2003 26 4 218 221
130. Carrey N., Normand.Carrey@iwk.nshealth.ca MacMaster F. P., Sparkes S. J., Khan S. C., Kusumakar V., Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. Journal of Child and Adolescent Psychopharmacology 2002 12 4 331 336 2-s2.0-0035684093 10.1089/104454602762599871 (Pubitemid 36169285)
131. Bottomley P. A., The trouble with spectroscopy papers. Radiology 1991 181 2 344 350 2-s2.0-0025991464
132. Kreis R., Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR in Biomedicine 2004 17 6 361 381 2-s2.0-5044228017 10.1002/nbm.891 (Pubitemid 39335175)
133. Taylor J. S., The trouble with spectroscopy papers, 15 years later. NMR in Biomedicine 2006 19 4 409 410 2-s2.0-33745712480 10.1002/nbm.1064 (Pubitemid 43997762)
134. Tate A. R., Underwood J., Acosta D. M., Julià-Sapé M., Majós C., Moreno-Torres À., Howe F. A., van der Graaf M., Lefournier V., Murphy M. M., Loosemore A., Ladroue C., Wesseling P., Bosson J. L., Cabañas M. E., Simonetti A. W., Gajewicz W., Calvar J., Capdevilla A., Wilkins P. R., Bell B. A., Rémy C., Heerschap A., Watson D., Griffiths J. R., Arús C., Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR in Biomedicine 2006 19 4 411 434 2-s2.0-33745402707 10.1002/nbm.1016 (Pubitemid 43997763)
135. van der Graaf M., Julià-Sapé M., Howe F. A., Ziegler A., Majós C., Moreno-Torres A., Rijpkema M., Acosta D., Opstad K. S., van der Meulen Y. M., Arús C., Heerschap A., MRS quality assessment in a multicentre study on MRS-based classification of brain tumours. NMR in Biomedicine 2008 21 2 148 158 2-s2.0-40449083592 10.1002/nbm.1172 (Pubitemid 351351007)
136. Garcia-Gomez J. M., Luts J., Julia-Sape M., Krooshof P., Tortajada S., Robledo J. V., Melssen W., Fuster-García E., Olier I., Postma G., Monleón D., Moreno-Torres A., Pujol J., Candiota A.-P., Martínez-Bisbal M. C., Suykens J., Buydens L., Celda B., Van Huffel S., Arús C., Robles M., Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy. Magnetic Resonance Materials in Physics, Biology and Medicine 2009 22 1 5 18 2-s2.0-60549113497 10.1007/s10334-008-0146-y
137. Kato T., Takahashi S., Shioiri T., Inubushi T., Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. Journal of Affective Disorders 1992 26 4 223 230 2-s2.0-0026453704 10.1016/0165-0327(92)90099-R
138. Davanzo P., Thomas M. A., Yue K., Oshiro T., Belin T., Strober M., McCracken J., Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001 24 4 359 369 2-s2.0-0035137636 10.1016/S0893- 133X(00)00207-4 (Pubitemid 32157552)
139. DelBello M. P., Cecil K. M., Adler C. M., Daniels J. P., Strakowski S. M., Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2006 31 6 1264 1273 2-s2.0-33745643161 10.1038/sj.npp.1300950 (Pubitemid 43971842)
140. Patel N. C., DelBello M. P., Cecil K. M., Adler C. M., Bryan H. S., Stanford K. E., Strakowski S. M., Lithium treatment effects on myo-inositol in adolescents with bipolar depression. Biological Psychiatry 2006 60 9 998 1004 2-s2.0-33750039980 10.1016/j.biopsych.2006.07.029 (Pubitemid 44584217)
141. Patel N. C., DelBello M. P., Cecil K. M., Stanford K. E., Adler C. M., Strakowski S. M., Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. Journal of Child and Adolescent Psychopharmacology 2008 18 2 132 139 2-s2.0-42549097856 10.1089/cap.2007.0088 (Pubitemid 351591441)
142. Chang K., Karchemskiy A., Kelley R., Howe M., Garrett A., Adleman N., Reiss A., Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: a pilot study. Journal of Child and Adolescent Psychopharmacology 2009 19 1 51 59 2-s2.0-60749126923 10.1089/cap.2008.060
143. Dickstein D. P., Towbin K. E., Van Der Veen J. W., Rich B. A., Brotman M. A., Knopf L., Onelio L., Pine D. S., Leibenluft E., Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. Journal of Child and Adolescent Psychopharmacology 2009 19 1 61 73 2-s2.0-60949107409 10.1089/cap.2008.044